NDIS Low Cost Assistive Technology Guide
CueDose · NDIS Low Cost Assistive Technology
Support your case for CueDose as a Low Cost AT item
CueDose is a low-cost electronic medication reminder, developed by an Australian pharmacist for people who need extra support to take medication independently. This page is here to help participants, support coordinators, OTs and plan managers understand where CueDose fits within NDIS Low Cost Assistive Technology funding.
↓ Download as PDFWhere CueDose fits in NDIS funding
The NDIA's guidance allows Low Cost Assistive Technology under $1,500 to generally be purchased without quotes, assessments or prior approval, provided it's directly related to the participant's disability, low risk, funded within their plan, and reasonable and necessary. At $64.99 for a single device or $104.99 for the AM/PM bundle, CueDose sits comfortably within that category.
CueDose is not a formally listed or NDIA-approved AT item. Whether it's an appropriate purchase always comes down to the individual participant's functional needs and how clearly those needs connect to the device. This guide is intended to help you make that assessment, not to guarantee funding.
Who CueDose tends to suit
Stronger candidates
- Cognitive impairment or intellectual disability
- Autism
- Acquired brain injury
- Memory impairment
- Executive functioning difficulties
- Medication adherence issues caused by disability
Weaker candidates
- Occasional forgetfulness with no disability link
- Age-related forgetfulness alone
- Convenience, with no functional impact named
The clearer the connection to disability, the easier CueDose is to justify. Suitability should always be based on the participant's functional impairment rather than diagnosis alone. CueDose may be relevant for participants living with conditions such as Autism Spectrum Disorder, ADHD, intellectual disability, acquired brain injury, Parkinson's disease, multiple sclerosis, cerebral palsy, epilepsy, schizophrenia, bipolar disorder, dementia or stroke, where medication management is affected.
How CueDose may support NDIS outcomes
- Increased independence
- Development of daily living skills
- Improved medication adherence
- More consistent daily routines
- Reduced reliance on carers for prompting
- Greater confidence managing medication
- Fewer missed doses
- Safer, more consistent medication management
Suggested justification wording
Support coordinators, OTs and plan managers are welcome to adapt the wording below when documenting why CueDose is being requested.
Product at a glance
Features include a loud audible alarm, flashing visual alert, optional smartphone app connectivity, medication history tracking, rechargeable USB-C battery, and a portable, lightweight design. Australian owned.
CueDose was developed by Australian pharmacist Julie Williams, after seeing how many people living with disability were relying on inconsistent phone reminders or support worker prompting to manage essential medications. CueDose was designed as a simple, affordable assistive technology that supports independence and medication adherence.
Have questions about a specific participant?
Get in touch and we're happy to help you work through whether CueDose is an appropriate fit.
Contact CueDoseCueDose is not a registered or NDIA-approved assistive technology item. This page is provided as general information to help participants, families, support coordinators, plan managers and OTs consider whether CueDose may be an appropriate Low Cost Assistive Technology support. It is not funding advice, and does not guarantee NDIS approval. Funding decisions are always made based on the individual participant's plan, goals and functional needs.
"That’s why I created CueDose: we sell a smart, app-connected pill organiser designed to help people stay on track with their daily medications - without stress, shame, or sticky notes."
Julie Williams - Pharmacist & CueDose Founder
